{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:09:32Z","timestamp":1792012172013,"version":"4.4.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015034","name":"Shahid Sadoughi University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clim.2025.110640","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:39:58Z","timestamp":1763347198000},"page":"110640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Leukemia inhibitory factor (LIF) in acute graft-versus-host disease: A hypothesis-generating review"],"prefix":"10.1016","volume":"282","author":[{"given":"Ahmad","family":"Meshkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Erfan","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam sadat","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Badiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Masoud","family":"Khodaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110640_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current concepts and advances in graft-versus-host disease immunology","volume":"39","author":"Hill","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5045\/br.2023.2022192","article-title":"Effects of immune system cells in GvHD and corresponding therapeutic strategies","volume":"58","author":"Tavaf","year":"2023","journal-title":"Blood Res."},{"issue":"11","key":"10.1016\/j.clim.2025.110640_bb0015","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3324\/haematol.2019.240309","article-title":"Translational and clinical advances in acute graft-versus-host disease","volume":"105","author":"Gooptu","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","article-title":"Leukemia inhibitory factor (LIF)","volume":"26","author":"Nicola","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2025.110640_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107754","article-title":"The emerging role of leukemia inhibitory factor in cancer and therapy","volume":"221","author":"Zhang","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.clim.2025.110640_bb0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41419-020-02790-6","article-title":"LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndrome","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2025.110640_bb0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbi.2014.11.010","article-title":"Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis","volume":"45","author":"Janssens","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"4 Suppl","key":"10.1016\/j.clim.2025.110640_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/imt.11.30","article-title":"IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-\u03b3","volume":"3","author":"Jeannin","year":"2011","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.clim.2025.110640_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/08923973.2019.1619761","article-title":"Leukemia inhibitory factor (LIF) modulates the development of dendritic cells in a dual manner","volume":"41","author":"Yaftiyan","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.clim.2025.110640_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2017.00079","article-title":"Pathophysiology of GvHD and other HSCT-related major complications","volume":"8","author":"Ghimire","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.clim.2025.110640_bb0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0065","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/hematology.2021000301","article-title":"Updates in chronic graft-versus-host disease","volume":"2021","author":"Hamilton","year":"2021","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"10","key":"10.1016\/j.clim.2025.110640_bb0070","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bbmt.2017.06.011","article-title":"Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease","volume":"23","author":"Kurosawa","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.clim.2025.110640_bb0075","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/balkanmedj.2017.0055","article-title":"A review of Myeloablative vs reduced intensity\/non-Myeloablative regimens in allogeneic hematopoietic stem cell transplantations","volume":"34","author":"Atilla","year":"2017","journal-title":"Balkan Med. J."},{"issue":"6","key":"10.1016\/j.clim.2025.110640_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clim.2025.110640_bb0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MOH.0b013e32833eb770","article-title":"Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Hansen","year":"2010","journal-title":"Curr. Opin. Hematol."},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199602013340501","article-title":"Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation","volume":"334","author":"Goulmy","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.clim.2025.110640_bb0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.immuni.2019.06.003","article-title":"T cell recruitment to the intestinal stem cell compartment drives immune-mediated intestinal damage after allogeneic transplantation","volume":"51","author":"Fu","year":"2019","journal-title":"Immunity"},{"issue":"42","key":"10.1016\/j.clim.2025.110640_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay8556","article-title":"T cell-derived interferon-\u03b3 programs stem cell death in immune-mediated intestinal damage","volume":"4","author":"Takashima","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2025.110640_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40364-019-0167-x","article-title":"Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?","volume":"7","author":"Zhao","year":"2019","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbmt.2013.10.009","article-title":"Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T cells","volume":"20","author":"Shand","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0125","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2007-12-126987","article-title":"Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease","volume":"112","author":"Yi","year":"2008","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.clim.2025.110640_bb0130","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1182\/blood-2011-03-340315","article-title":"Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and ROR\u03b3t in mice","volume":"118","author":"Yu","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clim.2025.110640_bb0135","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899595","article-title":"STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation","volume":"38","author":"Zhang","year":"2019","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.clim.2025.110640_bb0140","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4161\/cc.8.9.8348","article-title":"Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6","volume":"8","author":"Gao","year":"2009","journal-title":"Cell Cycle"},{"issue":"18","key":"10.1016\/j.clim.2025.110640_bb0145","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1182\/blood-2011-09-377325","article-title":"Th1 and Th17 join forces for acute GVHD","volume":"118","author":"Teshima","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051033","article-title":"Regulation of T(H)17 cells and associated cytokines in wound healing, tissue regeneration, and carcinogenesis","volume":"18","author":"Brockmann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.clim.2025.110640_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/17474086.2020.1709436","article-title":"The role of regulatory T cells in graft-versus-host disease management","volume":"13","author":"Whangbo","year":"2020","journal-title":"Expert Rev. Hematol."},{"issue":"10","key":"10.1016\/j.clim.2025.110640_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah7152","article-title":"Eomesodermin promotes the development of type 1 regulatory T (T(R)1) cells","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0165","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/cmi.2015.44","article-title":"Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance","volume":"12","author":"Zeng","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2025.110640_bb0170","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1172\/JCI133909","article-title":"Donor monocyte-derived macrophages promote human acute graft-versus-host disease","volume":"130","author":"Jardine","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.clim.2025.110640_bb0175","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1172\/JCI75935","article-title":"CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease","volume":"124","author":"Alexander","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0180","article-title":"Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease. JCI","volume":"3","author":"Santos","year":"2018","journal-title":"Insight"},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0185","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136774","article-title":"Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction","volume":"131","author":"Tian","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0190","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.immuni.2019.08.011","article-title":"MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota","volume":"51","author":"Koyama","year":"2019","journal-title":"Immunity"},{"issue":"19","key":"10.1016\/j.clim.2025.110640_bb0195","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.2022015677","article-title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110640_bb0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.clim.2025.110640_bb0205","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1182\/blood-2009-05-222265","article-title":"Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR\/HLA-class I interaction","volume":"114","author":"Marcenaro","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bcmd.2007.06.029","article-title":"NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Ruggeri","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.clim.2025.110640_bb0215","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2017.00465","article-title":"Natural killer cells in graft-versus-host-disease after allogeneic hematopoietic cell transplantation","volume":"8","author":"Simonetta","year":"2017","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.clim.2025.110640_bb0220","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood-2005-04-1644","article-title":"KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation","volume":"106","author":"Cooley","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clim.2025.110640_bb0225","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00007890-199308000-00031","article-title":"Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice","volume":"56","author":"Xun","year":"1993","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0230","first-page":"98","article-title":"Leukemia inhibitory factor suppresses NKG2D mRNA expression and presentation on human natural killer cells","volume":"20","author":"Abdoli","year":"2021","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.clim.2025.110640_bb0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5050","key":"10.1016\/j.clim.2025.110640_bb0240","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1542794","article-title":"The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor","volume":"255","author":"Gearing","year":"1992","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0245","article-title":"Historical overview of the interleukin-6 family cytokine","volume":"217","author":"Kang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2025.110640_bb0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2019.11.005","article-title":"Leukemia inhibitory factor: recent advances and implications in biotechnology","volume":"52","author":"Pinho","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.clim.2025.110640_bb0255","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1158\/1535-7163.MCT-19-0605","article-title":"Stem cell factor lifted as a promising clinical target for cancer therapy","volume":"18","author":"Shi","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.clim.2025.110640_bb0260","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.gendis.2021.04.003","article-title":"Targeting LIF\/LIFR signaling in cancer","volume":"9","author":"Viswanadhapalli","year":"2022","journal-title":"Genes Dis."},{"issue":"3","key":"10.1016\/j.clim.2025.110640_bb0265","doi-asserted-by":"crossref","first-page":"788","DOI":"10.18632\/oncotarget.1772","article-title":"LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2025.110640_bb0270","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/ncomms6218","article-title":"LIF negatively regulates tumour-suppressor p53 through Stat3\/ID1\/MDM2 in colorectal cancers","volume":"5","author":"Yu","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/nyas.14466","article-title":"Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-hippo-YAP pathway","volume":"1484","author":"Bian","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"13","key":"10.1016\/j.clim.2025.110640_bb0280","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2007-02-072587","article-title":"Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells","volume":"110","author":"Duluc","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clim.2025.110640_bb0285","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1349-7006.2009.01286.x","article-title":"Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+ na\u00efve T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro","volume":"100","author":"Zhao","year":"2009","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0290","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-019-10369-9","article-title":"LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8(+) T cell tumor-infiltration impairing anti-PD1 therapy","volume":"10","author":"Pascual-Garc\u00eda","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.clim.2025.110640_bb0295","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6","article-title":"Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways","volume":"66","author":"Kellokumpu-Lehtinen","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.clim.2025.110640_bb0300","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.celrep.2014.04.036","article-title":"LIF mediates proinvasive activation of stromal fibroblasts in cancer","volume":"7","author":"Albrengues","year":"2014","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.clim.2025.110640_bb0305","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.TP.0000149324.42994.38","article-title":"Leukemia inhibitory factor is linked to regulatory transplantation tolerance","volume":"79","author":"Metcalfe","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2025.110640_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2020.105684","article-title":"Production and characterization of recombinant human leukemia inhibitory factor and evaluation of anti-fertility effects of rabbit anti-rhLIF in Balb\/c mice","volume":"174","author":"Zare","year":"2020","journal-title":"Protein Expr. Purif."},{"issue":"Pt A","key":"10.1016\/j.clim.2025.110640_bb0315","article-title":"Study the effect of recombinant leukemia inhibitory factor on maintenance of pregnancy and frequency of regulatory T cells in abortion-prone mice","volume":"124","author":"Ansariniya","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.clim.2025.110640_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71014-0","article-title":"Impact of anti leukemia inhibitory factor antibody on immune related gene expression in breast cancer Balb\/c mouse model","volume":"14","author":"Seifati","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.clim.2025.110640_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020217","article-title":"Leukemia inhibitory factor: an important cytokine in pathologies and Cancer","volume":"12","author":"Jorgensen","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.clim.2025.110640_bb0330","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1158\/1078-0432.CCR-21-1888","article-title":"Therapeutic targeting of LIF overcomes macrophage-mediated immunosuppression of the local tumor microenvironment","volume":"29","author":"Hallett","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.clim.2025.110640_bb0335","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.4049\/jimmunol.1900604","article-title":"Leukemia inhibitory factor inhibits Plasmacytoid dendritic cell function and development","volume":"204","author":"Sesti-Costa","year":"2020","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2025.110640_bb0340","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110640_bb0345","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3389\/fimmu.2019.00988","article-title":"The IL-12 cytokine and receptor family in graft-vs.-host disease","volume":"10","author":"Bastian","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:51:42Z","timestamp":1766152302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625002153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":69,"alternative-id":["S1521661625002153"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110640","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukemia inhibitory factor (LIF) in acute graft-versus-host disease: A hypothesis-generating review","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110640"}}